ABSTRACT
There is controversy regarding the relationship between the use of antidepressants in pregnancy and increased risk of impaired fetal growth, shorter gestation, congenital defects or other complications. Although tricyclic antidepressants have been used longest, their status as the safest treatment for depression in pregnancy remains controversial. Currently, selective serotonin reuptake inhibitors, except paroxetine, are thought to be the treatment of choice in depression during pregnancy. Some authors have found them as very safe but others have described some complications and congenital defects. In contrast, knowledge about the use of other groups of antidepressants in pregnant women is limited. Moreover, there is still much controversy about non-pharmacological treatment of depression in pregnancy. This paper includes a review of the literature referring to pharmacological and non-pharmacological treatment of unipolar depression in pregnancy.


Keywords: depression, pregnancy, fetus, antidepressants, electroconvulsive therapy.

Zdjęcie: Paweł Nowak

Piśmiennictwo

1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698-709

2. Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Radford K, Martinovic J, Ross LE. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013;74:e321-41

3. Headley J, Northstone K, Simmons H, Golding J. ALSPAC Study Team. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol 2004;60:355-661

4. Bakker MK, Kölling P, van den Berg PB, de Walle HE, de Jong van den Berg LT. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands. Br J Clin Pharmacol 2008;65(4):600-6

5. Hemels M, Einarson A, Koren G, Lanctot K, Einarson T. Antidepressant use during pregnancy and the rates of spontaneous abortions: a meta-analysis. Ann Pharmacother 2005;39(5):803-9

6. Chisolm MS, Payne JL. Management of psychotropic drugs during pregnancy. BMJ 2016;20:532:h5918. doi: 10.1136/bmj.h5918

7. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. General Hospital Psychiatry 2009;31:403-13

8. Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiology and Drug Safety 2007;16:1086-94

9. Reis M, Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychological Medicine 2010; 5. doi:10.1017/S0033291709992194

10. Fukushima N, Nanao K, Fukushima H, Namera A, Miura M. A neonatal prolonged QT syndrome due to maternal use of oral tricyclic antidepressants. Eur J Pediatr 2016;175(8):1129-32. doi: 10.1007/s00431-016-2722-x

11. Gentile S. Tricyclic antidepressants in pregnancy and puerperium. Expert Opin Drug Saf 2014;13(2):207-25. doi: 10.1517/14740338.2014.869582

12. Andrade SE, Raebel MA, Brown J et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.e1–194.e5

13. Kallen B, Otterblad Olausson P. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007;79:301-8

14. Oberlander TF. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76

15. Huybrechts KF, Hernández-Díaz S, Avorn J. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014;371(12):1168-9.doi: 10.1056/NEJMc1409203

16. Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, Mogun H, Setoguchi S. Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ. 2013;347:f4877. doi: 10.1136/bmj.f4877

17. Kim DR, Pinheiro E, Luther JF, Eng HF, Dills JL, Wisniewski SR, Wisner KL. Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage? J Psychiatr Res 2016;73:79-85. doi: 10.1016/j.jpsychires.2015.11.005

18. Ferreira E, Carceller AM, Agogué C et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics 2007;119:52-9. doi:10.1542/peds.2006-2133pmid:17200271

19. Warburton W, Hertzman C, Oberlander TF. A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health ActaPsychiatrScand.2010;121:4719.doi:10.1111/j.16000447.2009.01490.xpmid:19878137

20. Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, Hernández-Díaz S. Antidepressant use and risk for preeclampsia. Epidemiology 2013;24(5):682-91. doi: 10.1097/EDE.0b013e31829e0aaa

21. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011;68:1104-12

22. Rai D, Lee BK, Dalman C, Golding J, Lewis G, Magnusson C. Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013;346:f2059

23. Hviid A, Melbye M, Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 2013;369:2406-15

24. GlaxoSmithKline Bupropion Pregnancy Registry. Final report: 1 September 1997 through 31 March 2008.Registry Report. Wilmington, NC, 2008

25. Cole JA, Modell JG, Haight BR et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007;16:474-84. doi: 10.1002/pds.1296

26. Alwan S, Reefhuis J, Botto LD et al. Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol 2010;202:1.e1-6

27. Fokina VM, West H, Oncken C, Clark SM, Ahmed MS, Hankins GD, Nanovskaya TN. Bupropion therapy during pregnancy: the drug and its major metabolites in umbilical cord plasma and amniotic fluid. Am J Obstet Gynecol 2016;215(4):497.e1-7. doi: 10.1016/j.ajog.2016.05.016

28. Winterfeld U, Klinger G, Panchaud A, Stephens S, Arnon J, Malm H, Te Winkel B, Clementi M, Pistelli A, Maňáková E, Eleftheriou G, Merlob P, Kaplan YC, Buclin T, Rothuizen LE. Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol 2015;35(3):250-9. doi: 10.1097/JCP.0000000000000309

29. Einarson A, Bonari L, Voyer-Lavigne S, Addis A, Matsui D, Johnson Y, Koren G. A multicentre prospective controlled study to determine the safety of trazodone and nefazodone use during pregnancy. Can J Psychiatry 2003;48(2):106-10

30. Andrade C. The safety of duloxetine during pregnancy and lactation. J Clin Psychiatry 2014;75(12):e1423-7. doi: 10.4088/JCP.14f09631

31. Leiknes KA, Cooke MJ, Jarosch-von Schweder L, Harboe I, Høie B. Electroconvulsive therapy during pregnancy: a systematic review of case studies. Arch Womens Ment Health 2015;18(1):1-39. doi: 10.1007/s00737-013-0389-0

32. Malhotra N, Vani, Malhotra P, Bhardwaj R. Modified electroconvulsive therapy during pregnancy. J Anaesthesiol Clin Pharmacol 2008;24(3):351-2

33. Kasar M, Saatcioglu O, Kutlar T. Electroconvulsive therapy use in pregnancy. J ECT 2007;23(3):183-4

34. Anderson EL, Reti IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 2009;71(2):235-42

35. Bulbul F, Copoglu US, Alpak G, Unal A, Demir B, Tastan MF, Savas HA. Electroconvulsive therapy in pregnant patients. Gen Hosp Psychiatry 2013;35(6):636-9. doi: 10.1016/j.genhosppsych.2013.06.008

36. Calaway K, Coshal S, Jones K, Coverdale J, Livingston R. A Systematic Review of the Safety of Electroconvulsive Therapy Use During the First Trimester of Pregnancy. J ECT. 2016; 20. [Epub ahead of print]

37. Claridge AM. Efficacy of systemically oriented psychotherapies in the treatment of perinatal depression: a meta-analysis. Arch Womens Ment Health 2014;17:3-15

38. Sockol LE, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clin Psychol Rev 2011;31:839-49

39. St-André M. Psychotherapy during pregnancy: opportunities and challenges. Am J Psychother 1993;47:572-90

40. Molenaar MN, Brouwer ME, Bockting CLH , Bonsel GJ , van der Veere ChN, Torij HW, Hoogendijk WJG, Duvekot JJ, Burger H, Lambregtse-van den Berg MP. Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial. BMC Psychiatry 2016;16:72. doi: 10.1186/s12888-016-0752-6

41. Gaston A, Prapavessis H. Tired, moody and pregnant? Exercise may be the answer. Psychol Health 2013;28:1353-69

42. Oren DA, Wisner KL, Spinelli M et al. An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry 2002;159:666-9

43. Wirz-Justice A, Bader A, Frisch U et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry 2011;72:986-93

44. Hızlı Sayar G, Ozten E, Tufan E et al. Transcranial magnetic stimulation during pregnancy. Arch Womens Ment Health 2014;17:311-5

45. Dennis CL, Dowswell T. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database Syst Rev 2013;7:CD006795.pmid:23904069

46. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006;295(5):499-507. Erratum in: JAMA. 2006 Jul 12;296(2):170

Do góry